NOHO, INC.
ANNOUNCES ITS INTENT TO RAISE UP TO $20
MILLION THROUGH A REGULATION A TIER II
OFFERING
Scottsdale, AZ -- September 30, 2021 --
InvestorsHub NewsWire -- NOHO, Inc. (OTC
PINK: DRNK), a Wyoming corporation (the
"Company"), announced the following:
The Company intends to
raise up to $20 million through a Regulation A Tier II Offering
("Offering"). The proceeds from the offering will be used for brand
development and advertising spend as well as general
operations.
A portion of funding, if available,
will also be reserved for acquisition.
After a previous
successful transaction with Continuation Capital for the sale of
debt with Sibannac, Inc., the firm is expected to issue NOHO a
written Indication of Interest in the Offering up to $8
million. The
balance of the raise will be allocated between existing
shareholders and other institutional and private
investors.
The Company will be working with its
auditor to complete the necessary audits for the
Offering. Offering
details, including proposed share pricing, will be disclosed upon
filing the registration documents.
Product and Operations
Update
While Direct to
Consumer remains the primary sales model, as part of the product
roll-out plan the Company will be focusing resources in Las Vegas
and New York for brand awareness and partnership
opportunities. The
Company has provided a product development agreement to a Las
Vegas-based gaming influencer with a substantial social media
following, for a beverage additive. NOHO will
handling all formulation and product design
responsibility.
Consummation of the agreement is
expected within a week.
The sample product
featured on Twitter is a new formulation in the nootropics
category.
Nootropics are compounds that enhance
cognitive performance. This
formulation contains only natural, dietary supplements and would
not be subject to FDA approval. The Company will be providing more
information on this product in the near
future.
Warrants
The warrant
compensation for the transaction with Sibannac, Inc. is in final
stages of determination and will be announced through a joint
release upon completion.
More from NOHO – In addition to the After
Shot, we have developed a new line of products, all leveraging
Hydro-Nano technology, which will be rolling out soon. For
additional information and product updates, please follow us at
www.nohoshot.com and follow NOHO on
Twitter at https://twitter.com/NOHOdrink
Cautionary Note
Regarding Forward-Looking Statements.
This press release
contains statements that constitute forward-looking statements
within the meaning of Section 27A of the Securities
Act of 1933, as amended, and Section 21E of the Securities
Exchange Act of 1934, as amended. These
statements appear in a number of places in this release and
include all statements that are not
statements of historical fact regarding the intent, belief or
current expectations of Noho, Inc. (the
"Company"), its directors or its officers with respect to, among
other things: (i) financing plans; (ii)
trends affecting its financial condition or results of operations;
(iii) growth strategy and operating
strategy. The words "may," "would," "will," "expect," "estimate,"
"can," "believe," "potential" and similar
expressions and variations thereof are intended to identify
forward-looking statements. Investors are
cautioned that any such forward-looking statements are not
guarantees of future performance and involve
risks and uncertainties, many of which are beyond the Company's
ability to control, and actual results may differ materially from
those projected in the forward looking statements as
a result of various factors. You should not place undue reliance on
forward-looking statements since they involve known and unknown
risks, uncertainties and other factors, which are, in some cases,
beyond the Company's control and which could, and likely will,
materially affect actual results, levels of activity, performance
or achievements. The Company assumes no obligation to publicly
update or revise these forward-looking statements for any reason,
or to update the reasons actual results could differ materially
from those anticipated in these forward-looking statements, even if
new information becomes available in the future. Important factors
that could cause actual results to differ materially from the
company's expectations include, but are not limited to, those
factors that are disclosed under the heading "Risk Factors" and
elsewhere in documents filed by the company from time to time with
the United States Securities and Exchange Commission and other
regulatory authorities.
Contact:
IR@TheCampusCo.com
